Large gap with delayed quotes
|
Last quote
06/17/2026
-
23:20:00
|
Bid
06/17/2026 -
21:59:59
|
Bid Volume |
Ask
06/17/2026 -
21:59:59
|
Ask Volume |
|---|---|---|---|---|
|
81.89
+3.01
(
+3.82% )
|
81.84
|
100 |
81.92
|
400 |
Analysis date: 16.06.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 12.05.2026.
Interest
None
None
No stars since 09.06.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 09.06.2026 at a price of 84.57.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 02.06.2026.
4wk Rel Perf
-9.84%
-9.84%
The four-week dividend-adjusted underperformance versus SP500 is 9.84%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 21.04.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -1.52%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 5.50%.
Mkt Cap in $bn
4.51
4.51
With a market capitalization between $2 & $8bn, DIANTHUS THERAPEUTICS is considered a mid-cap stock.
G/PE Ratio
-0.94
-0.94
A negative ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) indicates that either the forecasted growth is decelerating (negative annualized growth estimate) or the financial analysts are expecting a loss (negative estimated PE).
LT P/E
-14.48
-14.48
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
-13.54%
-13.54%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
13
13
Over the last seven weeks, an average of 13 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
66
66
For 1% of index variation, the stock varies on average by 0.66%.
Correlation
0.07
0.07
Stock movements are totally independent of index variations.
Value at Risk
34.34
34.34
The value at risk is estimated at USD 34.34. The risk is therefore 43.54%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
21.04.2026
21.04.2026